About Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency
Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency is a rare disease catalogued by Orphanet (ORPHA:90793). It is associated with the CYP17A1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency trials.
Search ClinicalTrials.gov for "Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency" or filter by Orphanet code ORPHA:90793 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency. Updated daily.